Patents by Inventor John H. Dodd

John H. Dodd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dithiepino[6,5-b]pyridines, and related compositions and methods
    Publication number: 20020103376
    Abstract: This invention provides novel dithiepino[6,5-b]pyridines of the following formulae.
    Type: Application
    Filed: May 7, 2001
    Publication date: August 1, 2002
    Inventors: James L. Bullington, John H. Dodd, Daniel A. Hall
  • Benzosulfones and related compositions and methods
    Patent number: 6410553
    Abstract: This invention provides novel benzosulfones of the following formulae: These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity. Thus, this invention also provides pharmaceutical compositions, as well as methods, for preventing and treating disorders such as hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: June 25, 2002
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: John H. Dodd, Kenneth C. Rupert, James L. Bullington, Daniel A. Hall
  • Benzoether and related compositions and methods
    Patent number: 6410552
    Abstract: This invention provides novel benzoethers of the following formulae: These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity. Thus, this invention also provides pharmaceutical compositions, as well as methods, for preventing and treating disorders such as hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: June 25, 2002
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: John H. Dodd, James R. Henry, Kenneth C. Rupert, James L. Bullington, Daniel A. Hall
  • Benzosulfones and related compositions and methods
    Publication number: 20020049326
    Abstract: This invention provides novel benzosulfones of the following formulae: 1
    Type: Application
    Filed: December 28, 2000
    Publication date: April 25, 2002
    Inventors: John H. Dodd, Kenneth C. Rupert, James L. Bullington, Daniel A. Hall
  • Benzoether and related compositions and methods
    Publication number: 20020049325
    Abstract: This invention provides novel benzoethers of the following formulae: 1
    Type: Application
    Filed: December 28, 2000
    Publication date: April 25, 2002
    Inventors: John H. Dodd, James R. Henry, Kenneth C. Rupert, James L. Bullington, Daniel A. Hall
  • Dithiepino[6,5-b]pyridines, and related compositions and methods
    Publication number: 20020032332
    Abstract: This invention provides novel dithiepino[6,5-b]pyridines of the following formulae.
    Type: Application
    Filed: June 13, 2001
    Publication date: March 14, 2002
    Inventors: James L. Bullington, John H. Dodd, Daniel A. Hall
  • Dithiepino [6,5-b]pyridines, and related compositions and methods
    Publication number: 20020026051
    Abstract: This invention provides novel dithiepino[6,5-b]pyridines of the following formulae.
    Type: Application
    Filed: July 23, 2001
    Publication date: February 28, 2002
    Inventors: James L. Bullington, John H. Dodd, Daniel A. Hall
  • Dithiepino[6,5-b]pyridines, and related compositions and methods
    Patent number: 6291454
    Abstract: This invention provides novel dithiepino[6,5-b]pyridines of the following formulae. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthinatic and antibronchoconstriction activity. Thus, this invention also provides pharmaceutical compositions, as well as methods, for preventing and treating disorders such as hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: September 18, 2001
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: James L. Bullington, John H. Dodd, Daniel A. Hall
  • Substituted pyrrolobenzimidazoles for treating inflammatory diseases
    Patent number: 6147096
    Abstract: This invention provides compounds, and pharmaceutically acceptable salts thereof, having the structure shown below, as well as related pharmaceutical compositions, and methods of treatment and synthesis.
    Type: Grant
    Filed: February 25, 1999
    Date of Patent: November 14, 2000
    Assignee: Ortho McNeil Pharmaceutical, Inc.
    Inventors: John H. Dodd, James R. Henry, Kenneth C. Rupert
  • Substituted dibenz (A F)azulenes and methods of preparation
    Patent number: 5834521
    Abstract: Tetracyclic compounds having the following structure are described: ##STR1## wherein R.sub.1 -R.sub.10 are as defined. The tetracyclic compounds are capable of potent effects on steroid sensitive tissues and have demonstrated increased uterine weight, antiovulatory effects and potent steroid receptor binding. The compounds have therapeutic utility in reproductive applications such as fertility control, labor induction, ovulation induction and spermatogenesis. Methods for preparing the tetracyclic compounds from substituted indanones are also described.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: November 10, 1998
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: John H. Dodd, Lisa A. Dixon, James L. Bullington, Charles F. Schwender
  • Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
    Patent number: 5075440
    Abstract: Novel pyrido[2,3-f] [1,4]thiazepines and novel pyrido[3,2-b] [1,5]benzothiazepines of the formula: ##STR1## These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity. Also described are methods of producing the novel compounds and intermediates thereof.
    Type: Grant
    Filed: May 3, 1990
    Date of Patent: December 24, 1991
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: David J. Wustrow, Charles F. Schwender, John H. Dodd
  • Preparation of thiocycloalkno [3,2-b] pyridines
    Patent number: 4879384
    Abstract: Novel substituted thiacycloalkeno [3,2-b] pyridines are described. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstrictor activity.
    Type: Grant
    Filed: June 15, 1988
    Date of Patent: November 7, 1989
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Charles F. Schwender, John H. Dodd
  • Substituted thiacycloalkeno [3,2-b] pyridines
    Patent number: 4845225
    Abstract: Novel substituted thiacycloalkeno [3,2-b] pyridines are described. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstrictor activity.
    Type: Grant
    Filed: May 9, 1988
    Date of Patent: July 4, 1989
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Charles F. Schwender, John H. Dodd
  • Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
    Patent number: 4777167
    Abstract: Novel substituted thiacycloalkeno [3,2-b]pyridines are described. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstrictor activity.
    Type: Grant
    Filed: February 17, 1987
    Date of Patent: October 11, 1988
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Charles F. Schwender, John H. Dodd
  • Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents
    Patent number: 4745123
    Abstract: Certain substituted 1,2,3,6-tetrahydro- and 1,2,5,6-tetrahydropyridine-3-carboxylic acids, esters, and amides possessing muscarinic binding activity, having utility for the treatment of the symptoms of senile cognitive decline disclosed. Pharmaceutical compositions and a pharmaceutical method of treatment are also disclosed.
    Type: Grant
    Filed: February 18, 1986
    Date of Patent: May 17, 1988
    Assignee: Warner-Lambert Company
    Inventors: Donald E. Butler, John H. Dodd, Walter H. Moos, Haile Tecle
  • Substituted thiacycloalkeno (3,2-b) pyridines and pharmaceutical compositions and method of use
    Patent number: 4705785
    Abstract: Novel substituted thiacycloalkeno [3,2-b] pyridines are described. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstrictor activity.
    Type: Grant
    Filed: April 9, 1986
    Date of Patent: November 10, 1987
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Charles F. Schwender, John H. Dodd
  • Substituted 5,6-dialkoxyquinazoline derivatives
    Patent number: 4672116
    Abstract: Quinazoline derivatives having an oxy substituent in 5 and 6 positions are described. The novel quinazoline derivatives are useful as cardiotonic agents.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: June 9, 1987
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Victor T. Bandurco, Stanley C. Bell, John H. Dodd, Robert Falotico, Charles F. Schwender, Alfonso J. Tobia